TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation

被引：0
|
作者：
Carella, A. M. [1 ]
Palumbo, G. [2 ]
Greco, M. M. [1 ]
Merla, E. [1 ]
Dell'Olio, M. [1 ]
Pisapia, G. [3 ]
Mazza, P. [3 ]
Ferrara, F. [4 ]
Musto, P. [5 ]
Rana, A. [6 ]
Guarini, A. [6 ]
Di Tonno, P. [7 ]
Pastore, D. [8 ]
D'Elia, M. [8 ]
Specchia, G. [8 ]
Capalbo, S. [2 ]
Cascavilla, N. [1 ]
机构：
[1] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[2] United Hosp, Foggia, Italy
[3] Hosp G Moscati, Taranto, Italy
[4] Hosp Cardarelli, Naples, Italy
[5] CROB, Rionero In Vulture, Italy
[6] IRCCS Canc Inst, Bari, Italy
[7] Hosp Di Venere, Bari, Italy
[8] Univ Hematol, Bari, Italy
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [31] Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma
    Scortechini, Ilaria
    Montanari, Mauro
    Mancini, Giorgia
    Inglese, Elena
    Calandrelli, Monica
    Chiarucci, Martina
    Offidani, Massimo
    Capelli, Debora
    Gini, Guido
    Poloni, Antonella
    Mancini, Stefania
    Raggetti, Gianmario
    Leoni, Pietro
    Olivieri, Attilio
    LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1657 - 1660
  • [32] Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma
    Hyung, Jaewon
    Hong, Jung Yong
    Yoon, Dok Hyun
    Lee, Kyoungmin
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Ryu, Jin-Sook
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [33] Thiotepa and melphalan as a new conditioning regimen for autologous transplantation in multiple myeloma
    Grimaldi, F.
    Madonna, E.
    Avilia, S.
    Pane, F.
    Risitano, A. M.
    De Rosa, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S209 - S209
  • [34] Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients
    Mousavi, S.
    Alimoghaddam, K.
    khatami, F.
    Jahani, M.
    Iravani, M.
    Bahar, B.
    Khodabandeh, A.
    Jalali, A.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S381 - S382
  • [35] Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients
    Ghavamzadeh, A.
    Alimogaddam, K.
    Khatami, F.
    Gaffari, F.
    Ashuri, A.
    Mousavi, A.
    Iravani, M.
    Bahar, B.
    Jahani, M.
    Khodabande, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S133 - S134
  • [36] Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for Lymphoma
    Pasquini, Marcelo C.
    Le Rademacher, Jennifer
    Flowers, Christopher
    Lill, Michael
    Costa, Luciano J.
    Shore, Tsiporah B.
    Vaughan, William
    Craig, Michael
    Freytes, Cesar O.
    Shea, Thomas C.
    Horwitz, Mitchell E.
    Fay, Joseph W.
    Mineishi, Shin
    Rondelli, Damiano
    Mason, James
    Reddy, Vijay
    Braunschweig, Ira
    Ai, Weiyun
    Armstrong, Elizabeth
    Smith, Angela
    Zhao, Cathy
    Elekes, Agnes
    Carreras, Jeanette
    Kato, Kazunobu
    Waller, Edmund K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S162 - S162
  • [37] Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
    Okay, M.
    Buyukasik, Y.
    Demiroglu, H.
    Malkan, U.
    Ciftciler, R.
    Aladag, E.
    Aksu, S.
    Haznedaroglu, I.
    Sayinalp, N.
    Ozcebe, O.
    Goker, H.
    LEUKEMIA RESEARCH, 2018, 73 : S27 - S27
  • [38] Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
    Okay, Mufide
    Buyukasik, Yahya
    Demiroglu, Haluk
    Malkan, Umit Yavuz
    Ciftciler, Rafiye
    Aladag, Elifcan
    Aksu, Salih
    Haznedaroglu, Ibrahim Celalettin
    Sayinalp, Nilgun
    Ozcebe, Osman Ilhami
    Goker, Hakan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (04) : 985 - 992
  • [39] Thiotepa, Etoposide, Cyclophosphamide, ARA-C and Melphalan (TECAM) conditioning protocol for autologous stem cell transplantation - An alternative non BCNU containing regimen
    Grisariu, S.
    Shapira, M. Y.
    Or, R.
    Avni, B.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S441 - S441
  • [40] AUTOLOGOUS STEM CELL TRANSPLANTATION WITH BEEAM (BENDAMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN) IN AGGRESSIVE NHL AND HODGKIN'S LYMPHOMA
    Noesslinger, T.
    Moestl, M.
    Koller, E.
    Tinchon, C.
    Mulabecirovic, A.
    Linkesch, W.
    Sallaberger, E.
    Hundsamer, A.
    Keil, F.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S167 - S168
12345